Makino Sohei | 論文著者

Committee on the Safety of Sustained-Release Theophylline and Injectable Methylxanthines (CST) of th

Committee on the Safety of Sustained-Release Theophylline and Injectable Methylxanthines (CST) of the Committee for Asthma Prevention and Management Guidelines in the Japanese Society of Allergology

Committee on the Safety of Sustained-Release Theophylline and Injectable Methylxanthines (CST), Committee for Asthma Prevention and Management Guidelines in the Japanese Society of Allergology

Department Of Medicine And Clinical Immunology Dokkyo University School Of Medicine

Department of Medicine and Clinical Immunology, Dokkyo University School of Medicine

Department of Medicine, Dokkyo University Medical School

Department Of Pulmonary Medicine And Clinical Immunology Dokkyo University School Of Medicine

Department of Pulmonary Medicine and Clinical Immunology, Dokkyo University School of Medicine

Respiratory Medicine, Jobu Hospital for Respiratory Diseases, Japan

Tokyo Allergic Disease Research Institute

Tokyo Allergic Disease Research Institute Kihara Hospital

Tokyo Allergic Disease Research Institute, Kihara Hospital

Tokyo Allergy and Respiratory Disease Research Institute

Tokyo Allergy Disease Research Institute

World Health Organization Collaborating Centre of Prevention and Control of Chronic Respiratory Disease, Dokkyo Medical University

日本アレルギー学会